EJNMMI Research

Table 2 Lesion volumes as assessed on the [¹⁸F]FLT PET scans at the three time points: baseline, 7 days post-therapy and 28 days post-therapy

From: Validation of [¹⁸F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

	Baseline	7 days post-therapy	28 days post-therapy
Patients	Lesion volume (mL)
1	46.3	31.2	22.2
2	102.2	45.5	45.4
3	68.3	45.7	68.4
4	126.8	48.9	35.2
5	72.3	32.9	28.9
6	50.8	20.7	19.3

Back to article page